Freund's Incomplete Adjuvant
Freund's Incomplete Adjuvant - Related Videos
04:13
An Adjuvant Therapy in a Mouse Model with an Incompletely Resected Subcutaneous Tumor
0 Views •
2025
This video illustrates testing of adjuvant or additional therapy in a mouse model with incompletely resected subcutaneous tumors. The partially tumor-resected mouse is treated with an antibody targeting the anti-cytotoxic protein of T regulatory cells, potentially reducing tumor regrowth and suggesting effective adjuvant therapy.
03:29
A Technique to Generate an Adjuvant-Induced Arthritis Mouse Model
0 Views •
2025
This video demonstrates a method to generate adjuvant-induced arthritis in a murine model. Complete Freund's adjuvant (CFA) is injected in the mouse ankle joint and periarticular areas. CFA activates the immune system, leading to neutrophil infiltration and exaggerated inflammation.
01:50
Preparation of a Nanoemulsion Adjuvant Vaccine
0 Views •
2025
This video demonstrates the production of nanoemulsion tumor vaccines. The stable oil reservoir depots carrying synthetic peptides and adjuvants are produced by low-energy nanoemulsion, offering significant promise for tumor immunotherapy.
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
0 Views •
Cited by 7 •
2020
In this protocol, we describe a mouse model of incomplete surgical resection of soft tissue sarcoma for testing (neo)adjuvant therapies.
01:43
Incomplete Dominance
0 Views •
2021
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism. According to Mendel, organisms with both copies or a single copy of the dominant allele display a...
FAQs
The water-in-oil formulation helps retain antigen at the injection site, extending the period during which immune cells can encounter it. This sustained exposure can strengthen antigen-specific responses compared with brief antigen availability alone. The resulting antibody or cellular response still depends on the antigen used and the overall experimental design.
The key distinction is the absence of mycobacterial components in Freund's Incomplete Adjuvant. This allows investigators to enhance antigen-specific immunity without including that additional component found in the complete formulation. The comparison is important when interpreting immune outcomes, because adjuvant composition can influence how experimental responses are generated and evaluated.
FIA does not produce a uniform response independent of context. Its effects depend on the antigen and on experimental design, so studies may differ in the strength or character of antibody and cellular immunity they measure. Investigators therefore interpret results in relation to the selected antigen, formulation, and research objective rather than attributing every outcome to the adjuvant alone.
The formulation requires attention to the antigen, mineral oil, and surfactant that together create the intended water-in-oil preparation. These components determine the formulation used for exposure at the injection site. Because the source material does not specify operational mixing conditions, researchers should treat the exact preparation procedure as part of the experimental design rather than assume one universal workflow.
Researchers may select FIA when they need to strengthen an antigen-specific response in studies of infection, vaccine development, or immune regulation. It can support investigations of both antibody production and cellular immune responses. Its value is greatest when the study requires controlled evaluation of how a selected antigen shapes immunity under the planned experimental conditions.
Experiments can evaluate antigen-specific antibody production as well as cellular immune responses. These outcomes help researchers examine immune activation in infection models, assess vaccine-related responses, or study regulation of immunity. Interpretation should remain linked to the antigen and experimental design, since FIA supports the response but does not determine a single outcome in every study.